Risk Factors for Poor Prognosis in Patients With Cancer and COVID-19
Data from the CCC19 registry were evaluated to uncover risk factors associated with increased 30-day mortality in patients with cancer infected with COVID-19.
Cancer
Antihypertensive Drugs and Cancer Risk: Is There a Link?
Five antihypertensive drug classes were analyzed separately and were also compared to all other treatment groups, including placebo.
p16INK4a Expression Increased in Young Cancer Survivors
Signs of age acceleration at molecular level also seen in frail survivors, in children after cancer therapy.
Rates of Prescription Opioid Use Higher in Cancer Survivors
Cancer survivors have similar rates of prescription opioid misuse versus those without cancer.
MASCC Survey Identifies Research, Development Goals for Cancer Survivorship Care
A survey of MASCC clinician members identified 3 areas for further research and development to improve survivorship care plans for cancer survivors.
Trouble With Daily Activities Tied to Worse Cancer Outcomes
Authors call for routine assessment of functional status on hospital admission.
Restructured Process Overcomes Barriers to Prior Authorization for Proton Therapy
This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center.
How Cancer Care Can Affect the Kidney
Recent advances in cancer management may present challenges for nephrologists.
Cancer-Related Encounters Down Since Start of COVID-19
In addition, dramatic decreases in colorectal cancer and breast cancer screening observed.
BTK Inhibition May Counter Hyperinflammatory Response Associated With Severe COVID-19
In this study, emergency, unregistered use of acalabrutinib was available to patients hospitalized with advanced COVID-19 in accordance with the WHO MEURI guidelines.
-
Loading...
-
Loading...
Next post in Urology
